SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
PRECLINICAL STUDIES OF NEW PREVENTION INTERVENTIONS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
SESSION OVERVIEW-PRECLINICAL STUDIES OF NEW PREVENTION INTERVENTIONS
Ariane van der Straten
University of California San Francisco, Kensington, CA, United States
LENACAPAVIR PROTECTS AGAINST RECTAL SHIV ACQUISITION IN MACAQUE MODEL (ABSTRACT
992)
Elena Bekerman
Gilead Sciences, Inc, Foster City, CA, United States
EXTENDED POST-EXPOSURE PROTECTION AGAINST SHIV VAGINAL INFECTION WITH TAF/EVG INSERTS (ABSTRACT
990)
Natalia Makarova
Centers for Disease Control and Prevention, Atlanta, GA, United States
VAGINAL PREP EFFICACY OF BIODEGRADABLE ISLATRAVIR IMPLANTS IN MACAQUES (ABSTRACT
989)
Michele B. Daly
Centers for Disease Control and Prevention, Atlanta, GA, United States
PHARMACOKINETICS AND XRAY IMAGING OF LONG-ACTING CABOTEGRAVIR IN SITU FORMING IMPLANT (ABSTRACT
991)
Isabella Young
University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Ariane van der Straten
University of California San Francisco, Kensington, CA, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
